| NCT Number | NCT07349589 |
| Lead Sponsor | Daewon Pharmaceutical Co., Ltd. |
| Conditions | Healthy Adult |
| Enrollment | 48 participants |
| Start Date | 2026-02-01 |
| Primary Completion | 2026-02-28 (estimated) |
| Study Completion | 2026-12-01 (estimated) |
| Updated on ClinicalTrials.gov | 2026-01-20 |